Pharmaceutical

Pfizer sells 7.3% stake in Haleon for $3.3bn

Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.

Mar 21, 2025 - 06:00
Pfizer sells 7.3% stake in Haleon for $3.3bn
Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.
Read the original article

Tags:

Previous Article

Roche’s discontinued Alzheimer’s drug shows signs of preventing onset

Next Article

Oxford BioTherapeutics and Roche link on antibody cancer treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sanders blames food companies for diabetes epidemic

STAT+: Sanders blames food companies for diabetes epidemic

Dec 15, 2023

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance

Insmed’s gene therapy poised to challenge DMD landscape...

Jan 16, 2025

STAT+: Lobbying spending dropped for companies that departed PhRMA

STAT+: Lobbying spending dropped for companies that dep...

Jul 24, 2023